DPTIP-prodrug 18

Overview

DPTIP -proagent 18 (P18) is a orally active and brain-penetrable proagent of DPTIP ( HY-131002 ). DPTIP -proagent 18 is a potent nSMase2 inhibitor. DPTIP -proagent 18 significantly inhibits IL-1β-induced EV (extracellular vesicle) release by inhibition of nSMase2 (neutral sphingomyelinase-2) activity. DPTIP -proagent 18 can be used for brain injury research.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Phospholipase

Product Information

• Catalog No.: HY-149025
• CAS No.: 2881068-33-1
• Molecular Formula: C36H44N4O4S
• Molecular Weight: 628.82
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source